These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37194229)

  • 21. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.
    Ma M; Xie W; Li X
    Int J Gen Med; 2021; 14():3163-3176. PubMed ID: 34262330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome.
    Chen Y; Ma L; Ge Z; Pan Y; Xie L
    Front Mol Biosci; 2022; 9():888194. PubMed ID: 35693550
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathogenic gene connections in type 2 diabetes and non-alcoholic fatty liver disease: a bioinformatics analysis and mouse model investigations experiments.
    Chen C; Yang K; Zhang Y; Lu M; Zhao X; Wan Z
    Nutr Diabetes; 2024 Aug; 14(1):60. PubMed ID: 39107295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.
    Wang H; Cheng W; Hu P; Ling T; Hu C; Chen Y; Zheng Y; Wang J; Zhao T; You Q
    Front Immunol; 2024; 15():1335112. PubMed ID: 38476236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis.
    Qi S; Wang C; Li C; Wang P; Liu M
    Medicine (Baltimore); 2017 Aug; 96(32):e7743. PubMed ID: 28796060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis.
    Li X; Zhong S; Sun Y; Huang X; Li Y; Wang L; Wu Y; Yang M; Yuan HX; Liu J; Zang S
    Front Endocrinol (Lausanne); 2022; 13():951093. PubMed ID: 36329886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.
    Li G; Lu Z; Chen Z
    Front Immunol; 2024; 15():1424308. PubMed ID: 39351239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.
    Chang Y; He J; Xiang X; Li H
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101435. PubMed ID: 32386798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis.
    Mahmoudi A; Butler AE; Jamialahmadi T; Sahebkar A
    Biomed Res Int; 2021; 2021():3654660. PubMed ID: 34988225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
    Zhou W; Ma CX; Xing YZ; Yan ZY
    Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis.
    Zhan Z; Chen Y; Duan Y; Li L; Mew K; Hu P; Ren H; Peng M
    PeerJ; 2019; 7():e6645. PubMed ID: 30923657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease.
    Wang R; Wang X; Zhuang L
    Ann Hepatol; 2016; 15(2):190-9. PubMed ID: 26845596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
    Chen C; Wu Y; Lu HL; Liu K; Qin X
    PeerJ; 2022; 10():e13138. PubMed ID: 35313524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
    Cai C; Song X; Yu C
    Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene microarray analysis of expression profiles in Suberoyllanilide hyroxamic acid-treated Dendritic cells.
    Zhang J; Liu Y; Shi G
    Biochem Biophys Res Commun; 2019 Jan; 508(2):392-397. PubMed ID: 30502083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
    Liu J; Cheng Z
    Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and evaluation of key genes in contributing to pathogenesis of hepatic fibrosis based on microarray data.
    Wu F; Ning L; Zhou R; Shen A
    Eur J Med Res; 2020 Sep; 25(1):43. PubMed ID: 32943114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.